ABSTRACT:Objective of presented study was to compare intravenous iron sucrose and ferric carboxymaltose therapy in iron deficiency anemia duringpregnancy and postpartum period. Methods: A clinical observational study was undertaken at tertiary care teaching hospital over a period of4 months in 30 pregnant women and 30 post partum women. The baseline hemoglobin and serum ferritin levels were recorded prior totreatment. After completion of the treatment the women were followed up for changes in hemoglobin and serum ferritin levels on day 8 andday 15. The mean rise of hemoglobin value was 5.2 for ferric carboxymaltose and 4.1 g/L for iron sucrose in pregnant women. Forpostpartum women mean rise of hemoglobin was 4.9 on the 15th day of treatment. Side effects were reported in 40% among patients treatedwith iron sucrose as compared to 16.67% in case of ferric carboxymaltose. Ferric carboxymaltose administration in pregnant women is safeand well tolerated by pregnant as well as post partum women. Ferric carboxymaltose is associated with fewer side effects as compared toiron sucrose in present study. It also offers the advantage of a much higher iron dosage at a time reducing the need for repeated applicationsand increasing patients' comfort.KEYWORDS: Anemia; ferric carboxymaltose; hemoglobin; intravenous iron therapy; iron deficiency; iron sucrose; pregnancy

ABSTRACT: Helicobacter pylorus (H. pylori) is one of the most common pathogenic bacterial infections and is found in the stomachs of approximately halfof the world's popula- tion. It is the primary known cause of gastritis, gastro- duodenal ulcer disease and gastric cancer. However, combineddrug therapy as the general treatment in the clinic, the rise of antibiotic-resistant bacteria, adverse reactions and poor patient compliance aremajor ob- stacles to the eradication of H. pylori . Oral site-specific drug delivery systems that could increase the longevity of the treatmentagent at the target site might improve the therapeutic effect and avoid side effects. Gastro- retentive drug delivery systems potentially prolongthe gastric retention time and controlled/sustained release of a drug, thereby increasing the concentration of the drug at the application site,potentially improving its bioavailability and reducing the necessary dosage.KEY WORDS: Helicobacter pylorus, Floating Drug Delivery, Gastro-Retentive

ABSTRACT: Rifampicin is a first line medication used as an anti-tubercular agent. Rifampicin acts by binding and inhibiting DNA dependent RNApolymerase. It is active against gram positive and negative both types of bacteria . The clinical and pharmaceutical analysis of this drugrequires effective analytical procedures for quality control and pharmacodynamic and pharmacokinetic studies as well as stability study. Anextensive survey of the literature published in various analytical and pharmaceutical chemistry related journals has been conducted and theinstrumental analytical methods which were developed and used for determination of Rifampicin as single or combination with other drugs inbulk drugs, formulations and biological fluids have been reviewed. This review covers the time period from 1997 to 2014 during which 33analytical methods including spectrophotometric methods like UV and derivative; visible which is based on formation of metal complexation,spectrofluorometric methods and chromatographic method including HPLC, HPTLC, and miscellaneous method like HPLC-MS were reported.The application of these methods for the determination of Rifampicin in pharmaceutical dosage form and biological samples has also beendiscussed. KEY WORDS: Rifampicin, UV spectroscopy, HPLC, HPLC-MS, HPTLC Cobalt complexes

ABSTRACT:Mouth dissolving film is the most advanced oral solid dosage form due to its flexibility and comfort in use. Mouth dissolving films are oral soliddosage form that disintegrate and dissolve within a minute when placed in mouth without taking water or chewing. This dosage form allows themedication to bypass the first pass metabolism so bioavailability of medication may be improved .Mouth dissolving film has potential to improveonset of action lower the dosing and eliminate the fear of chocking. Formulation of mouth dissolving films involves both the visual andperformance characteristics as plasticized hydrocolloids, API taste masking agents are being laminated by solvent casting and semisolid casting method. Solvent casting method being the most preferred method over other methods because it offers great uniformity of thickness and filmsprepared having fine glossy look and better physical properties. Mouth dissolving films are evaluated for its various parameters like thickness,physical property like folding endurance, disintegration and dissolution time. This review gives an idea about formulation techniques, evaluationparameters, overview on packaging and some available marketed products of mouth dissolving films. KEY WORDS: Mouth dissolving film, solvent casting, fast disintegration

ABSTRACT:Bisphenol A (BPA) is a well-known endocrine-disrupting chemical found in the environment. Oral exposure from food is generally consideredthe major source of BPA exposure for all age groups for non-occupationally exposed individuals. Apart from its oestrogenic property there areuncertainties about its effects on liver functions at very low doses over short time exposure periods. This study was carried out to determinethe acute and sub-chronic exposure effects of BPA on the liver functions and plasma proteins of albino rats following oral administration. Tofive experimental groups each containing five (5) female rats was administered 50, 100, 150, 200, and 250 ?g BPA/kgbw/day. To the sixthcontrol group was given water. A replicate group of experimental rats were similarly treated for seven (7) days to ascertain possible sub-chronic effects. Animals were sacrificed at the end of the respective studies and sample specimens analyzed by routine diagnostic procedures for plasma protein profile and liver functions using Chemwell Chemical Analyzer. The result reveals significant decreases in serum totalprotein and albumin and elevated values of AST and ALT (suggesting liver damage) as well as alkaline phosphatase and bilirubin (suggestiveof jaundice).It is clear from the results that low doses of BPA exert adverse effects on the liver functions in the Wistar rats even for a shortexposure period. Histological evaluations of the livers did not reveal any gross lesion and microscopic analysis show normal hepaticparenchymal-vascular relationship with no fatty changes, apoptotic bodies nor hepatic necrosis.KEY WORDS: acute, sub chronic, toxicity,graded doses, bisphenol A, liver and functions

ABSTRACTSublingual route is a useful when rapidonset of action is desired with better patient compliance. The portion of drug absorbed through thesublingual blood vessels bypasses the hepatic first pass metabolism processes giving acceptable bioavailability. Fast dissolving drug delivery israpidly gaining acceptance as an important new drug delivery technology, which aim to enhance safety and efficacy of a drug molecule toachieve better patient compliance. Many patients find it difficult to swallow tablets and hard gelatin capsules particularly pediatric and geriatricpatients and do not take their medicines as prescribed. Difficulty in swallowing or dysphasia is seen to afflict nearly 35% of the generalpopulation. In some cases such as motion sickness, sudden episode of allergic attack or coughing and an unavailability of water, the swallowingof tablet or capsules may become difficult in such situation fast dissolving drug delivery system is useful.KEY WORDS: Sublingual film, rapid dissolving, water soluble polymers, patient compliance.

ABSTRACT:Pharmaceutical industries have received much interest in pharmaceutical research in the area of oral drug delivery. The purpose of writing thisreview on floating drug delivery systems (FDDS) was to compile the recent literature with special focus on the principal mechanism of floatationto achieve gastric retention. The recent developments of FDDS including the physiological and formulation variables affecting gastric retention,approaches to design single-unit and multiple-unit floating systems, and their classification and formulation aspects are covered in detail. Thesesystems help in continuously releasing the drug before it reaches the absorption window, thus ensuring optimal bioavailability. This manner mayincrease patient compliance and provides continuously controlled release administration of sparingly soluble drugs at the particular sites ofabsorption. In recent years scientific and technological advancements have been made in the research and development of rate-controlled oraldrug delivery systems by overcoming physiological adversities, such as short gastric residence times (GRT) and unpredictable gastric emptyingtimes (GET). During the last five decades, little oral delivery has been produced to act as a drug reservoir from which the active ingredients arespecified period of time released and at controlled the release rate. Several approaches are currently utilized in the prolongation of the GRT,including floating drug delivery systems (FDDS), also known as hydrodynamically balanced systems (HBS), swelling and expanding systems,polymeric bioadhesive systems, modified-shape systems, high-density systems, and other delayed gastric emptying devices. Method forpreparing FDDS is simple and straight forward, and as a result economically attractive. This review also summarizes the in vitro techniques, invivo studies to evaluate the performance, advantages, marketed products and application of floating systems. These systems are useful toseveral problems encountered during the development of a pharmaceutical dosage form.KEY WORDS: Floating Drug Delivery System (FDDS), Gastro Retentive Dosage Forms, Floating Dosage Form, Gastric Residence Time

ABSTRACT:Artificial neural network (ANN) operation is based upon the simulation of biological neural process abilities in the human brain. In past statisticformulation optimized by response surface methodology (RSM) is one of the techniques that have been employed to develop and formulatecontrolled release dosage forms but limitations to the RSM technique another technique called artificial neural networks (ANN) has recentlygained wide popularity in the development of controlled release dosage forms. In this review articles most powerfully technique ANN has beenoptimized the formulation in controlled release drug delivery systems. Artificial neural networks (ANNs) are biologically inspired computerprograms designed to simulate the way in which the human brain processes information. ANNs gather their knowledge by detecting thepatterns and relationships in data and learn (or are trained) through experience, not from programming. In this review, the basic ANN structure,the development of the ANN model and an explanation of how to use ANN to design and develop controlled release drug delivery systems arediscussed. The behaviour of a neural network is determined by the transfer functions of its neurons, by the learning rule, and by thearchitecture itself. The weights are the adjustable parameters and, in that sense, a neural network is a parameterized system. In addition, theapplications of ANN in the design and development of controlled release dosage forms are also summarized in this review. The potentialapplications of ANN methodology in the pharmaceutical sciences range from interpretation of analytical data, drug and controlled releasedosage form design through bio-pharmacy to clinical pharmacy. KEY WORDS: Artificial neural network, Controlled-release formulations, Drug delivery systems, Computer, Network architecture

ABSTRACT:The advantage of administering a single dose of a drug that is released over an extended period of time instead of numerous doses is now aday's area of interest for formulation scientists in Pharmaceutical industry. With many drugs the basic Goal of therapy is to achieve a steady-state blood or tissue level that is therapeutically effective and nontoxic for an extended period of time. Sustain release system are considereda wiser approach for the drugs with short half-lives and which require repeated dosing, they are easy to formulate and are irrespective ofabsorption process from gastrointestinal tract after oral administration. The basic rationale of sustained release drug delivery systemoptimizes the biopharmaceutical, pharmacokinetic and pharmacodynamics properties of a drug in such a way that its utility is maximized,side-effects are reduced and cure of the disease is achieved. There are several advantages of sustained release (matrix) drug delivery overconventional dosage forms like improved patient compliance due to less frequent drug administration, reduction of fluctuation in steady-statedrug levels, maximum utilization of the drug, increased safety margin of potent drug, Developing oral sustained release matrix tablet withconstant release rate has always been a challenge to the pharmaceutical technologist. Most of drugs, if not formulated properly, may readilyrelease the drug at a faster rate, and are likely to produce toxic concentration of the drug on oral administration.KEY WORDS: ODDS, Sustain release, Matrix system

ABSTRACT:Oral route is presently the gold standard in the pharmaceutical industry where it is regarded as the safest, most economical and most convenientmethod of drug delivery resulting in highest patient compliance. Recent advances in novel drug delivery (NDDS) aims to enhance safety andefficacy of drug molecule by formulating a convenient dosage form for ease of administration and to achieve better patient compliance. One suchapproach is orodispersible tablets (ODTs). ODTs are a solid unit dosage form, which disintegrates or dissolves rapidly in the mouth without thegeneral requirement for swallowing, the chewing and water. Yet, dysphasia is the most common disadvantage of conventional tablets. Toovercome such problems, certain innovative drug delivery systems, like 'Orodispersible Tablets' (ODT) have been developed. The aim of thisarticle is to review the ideal properties, significance, characteristics, choice of drug candidates, challenges in formulation, various technologiesfor preparation of ODTs, Patented technologies on ODTs, and Suitable drug candidates for ODTs, Evaluation tests of ODTs and Marketedproduct of ODTs.KEY WORDS: Orodispersible tablets, patented technologies, OTS, Novel drug delivery

ABSTRACT:Pharmaceutical care programs developed and implemented by the pharmacists are useful in improving quality of care of bothambulatory as well as hospitalized patients with diabetes and also with other chronic diseases such as, hypertension, asthma,dyslipidemia, heart failure and tuberculosis. In recent years, pharmacists in many practice settings have begun providingpatient-centered services with the goal of improving drug therapy outcomes through practices such as pharmaceutical care.30 patients of both the genders who were diagnosed with Diabetes Mellitus (either type 1 or type 2) and taking anti- diabeticagents were recruited for the study. Baseline HbA1c was performed. Patient counseling was provided regarding their disease,drugs and life-style modifications (including exercise, self-care activities, etc). Follow-up was taken every 4-5 weeks Post-counseling HbA1c was performed after 12 weeks to assess the impact of patient counseling on glycemic control.Mean Baseline HbA1c value of 30 patients was observed to be 8.37% having the standard deviation of 1.76. The lowest HbA1cof patient that was observed was 5.8% and the highest one was > 14%. Post-counseling HbA1c was performed after the end of12 weeks of each patient, starting from date of enrollment. The mean HbA1c found at the endpoint was 7.96% ± 1.58%. At theendpoint the lowest test result was noted to be 5.60% and highest was 13.30%. The paired T-test result showed that there wassignificant difference existed in the pre-counseling HbA1c and post-counseling HbA1c after 12 weeks. Thus patient counselingshowed significant reduction in HbA1c.Our study concluded that clinical pharmacist provided patient counseling in community settings has a positive impact onglycemic indices. KEY WORDS: Glycemic control, HbA1c, Clinical Pharmacist, Patient Counseling, Pharmaceutical Care, Diabetic Patients